Accordingly, the survival analysis of follow-up data showed that high expression of AURKA was notably correlated with shorter OS (p < 0.05) and EFS (p < 0.05) in ES patients at our center (Fig. 2G, H). This evidence concerns the gene AURKA and Ewing sarcoma.